Caplin Point listed on Forbes Asia’s “200 Best Under a Billion” for 2024
Caplin Point Laboratories Ltd has been recognized yet again in Forbes Asia’s 200 Best Under a Billion list for the year 2024, a compilation that underscores companies’ sustained and robust performance across critical benchmarks. Carefully selected from a substantial pool of more than 20,000 publicly
traded companies across the Asia-Pacific region, 200 enterprises with annual sales under $1 billion are chosen based on qualitative and quantitative metrics. The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity.
Commenting on the achievement, Mr. C.C. Paarthipan, Chairman said:
“Caplin Point Laboratories Ltd’s inclusion in Forbes Asia’s ‘200 Best Under a Billion’ list for the seventh time underscores our relentless pursuit of excellence and financial discipline. This recognition, a rare achievement for an Indian pharmaceutical company, reflects our ongoing efforts to strengthening cash
flows and ensuring consistent profitability. We are committed to upholding the highest standards in every aspect of our business, ensuring sustained growth and value creation for our stakeholders.”
About Caplin Point Laboratories Limited:
Caplin Point Laboratories Limited is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. Caplin Point is one of the few companies to show consistent high-quality growth in Revenues, Profits and Cash flow over
the last 15 years. The Company has state of the art manufacturing facilities that cater to a complete range of finished dosage forms. The Company has also entered regulated markets such as US through its Subsidiary Caplin Steriles Limited.
Caplin Point listed on Forbes “Asia’s 200 Best Under a Billion” list for 2024. Company has
appeared for the seventh time on this list (2014, 2015, 2016, 2021, 2022, 2023 and 2024) and was awarded “The Emerging Company of 2018” by Economic Times Family Business Awards
| Subscribe To Our Free Newsletter |
